Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 May;6(5-6):214-9.
doi: 10.18632/genesandcancer.64.

Chronic inflammation: is it the driver or is it paving the road for malignant transformation?

Affiliations

Chronic inflammation: is it the driver or is it paving the road for malignant transformation?

Kambiz Afrasiabi et al. Genes Cancer. 2015 May.

Abstract

Chronic inflammation in well-defined mouse models such as Giα2 knock out mouse has been shown to trigger formation and expansion of hypoxic niches and also leads to up regulation of NFĸB, offering cells which have adapted their genetic machinery to hypoxia a unique survival advantage. These adapted cells have been shown to acquire stem cell-like capabilities as shown by up regulation of stem cell markers. Such long lived cells become permanent residents in sub mucosa and acquire a malignant phenotype from long-term exposure to noxious environmental agents due to a barrier defect secondary to down regulation of barrier proteins such as Zo1 and Occludin. Indeed mitotic spindle disorientation in such mice has been proposed as another contributory factor to malignant transformation. Sterilization of bowel lumen of these mice through different techniques has prevented malignant transformation in the presence of chronic inflammation. These facts stand strongly against chronic inflammation as a true driver of carcinogenesis but clearly support its role in facilitating the emergence of the neoplastic clone.

Keywords: Chronic inflammation; Free energy; JAK2V617F; bioenergetics; driver mutation; electric field and cancer; metabolomics; p53 Rb.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST

The authors declare that they have no conflict of interest whatsoever.

Figures

Figure 1
Figure 1. Suppressed expression of CCL2 (MCP-l) in the GBM cell line U251HF expressing transfected PAX6 (2.1, 2.2, and 2.3) as compared with non-transfected (p), vector transfected (vi, v6) and negative PAX6-transfected (2.6) cells
Cells were grownin DMEM/F12 under normoxic condition with serum deprivation for 24 and 48 hours before getting subjected to the assays. (A) Real-time qRT-PCR measurement of CCL2 expression normalized to ACTB and compared to the level in U25 1HF (p) with serum deprivation for 24 hours, using SYBR-Green I master mix (Roche) and Light Cycler real time PCR instruments following methods described previously 1. (B) ELISA quantification of secreted MCP-1 from the same cells analyzed in A, using MCP-1 ELISA kit from Assay Designs (Michigan). Values include the mean + SD of 3 independent experiments. PAX6 level in each cell line / transfectants by western blot assay was shown in ref. .

Similar articles

Cited by

References

    1. Zhou Y.H., Raj V.R., Siegel E., Yu L. Standardization of Gene Expression Quantification by Absolute Real-Time qRT-PCR System Using a Single Standard for Marker and Reference Genes. Biomark Insights. 2010;5:79–85. - PMC - PubMed
    1. Afrasiabi K., M.-S. J. Free energy measurement distinguishes normal from cancer cell, offering a new perspective for curing cancer. OnLine Journal of Biological Sciences. 2013;12:11–125.
    1. Zhou Y.H., Wu X., Tan F., Shi Y.X., Glass T., LIu T.J., Wathen K., Hess K.R., Gumin J., Lang F. PAX6 suppresses growth of human glioblastoma cells. J Neuro-Oncology. 2005;71:223–229. - PubMed
    1. Warburg O. On the origin of cancer cells. Science (New York, N.Y.) (1956);123:309–314. - PubMed
    1. Kumar S., Donti T.R., Agnihotri N., Mehta K. Transglutaminase 2 reprogramming of glucose metabolism in mammary epithelial cells via activation of inflammatory signaling pathways. International journal of cancer. Journal international du cancer. 2014;134:2798–2807. - PubMed